Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Autoimmune Disorders

Free Subscription 22.07.2019 1 Acta Neurol Scand 1 Ann Neurol 2 BMC Neurol 2 Brain 3 Diabet Med 1 Diabetes 3 J Autoimmun 1 J Immunol 3 J Neurol 1 J Rheumatol 2 Lancet Neurol 2 Mult Scler 1 N Engl J Med 2 Neurology 1 Thyroid

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Acta Neurol Scand

1. GUGER M, Enzinger C, Leutmezer F, Kraus J, et al
   Real-life use of oral disease-modifying treatments in Austria.
   Acta Neurol Scand. 2019;140:32-39.
   PubMed     Text format     Abstract available
   
   

   
   Ann Neurol

2. JUREK B, Chayka M, Kreye J, Lang K, et al
   Human gestational NMDAR autoantibodies impair neonatal murine brain function.
   Ann Neurol. 2019 Jul 20. doi: 10.1002/ana.25552.
   PubMed     Text format     Abstract available
   
   

   
   BMC Neurol

3. BANSBACK N, Chiu JA, Carruthers R, Metcalfe R, et al
   Development and usability testing of a patient decision aid for newly diagnosed relapsing multiple sclerosis patients.
   BMC Neurol. 2019;19:173.
   PubMed     Text format     Abstract available
   
   
4. CHOU CC, Su IC, Chou IJ, Lin JJ, et al
   Correlation of anti-acetylcholine receptor antibody levels and long-term outcomes of juvenile myasthenia gravis in Taiwan: a case control study.
   BMC Neurol. 2019;19:170.
   PubMed     Text format     Abstract available
   
   

   
   Brain

5. HAUSLER D, Torke S, Peelen E, Bertsch T, et al
   High dose vitamin D exacerbates central nervous system autoimmunity by raising T-cell excitatory calcium.
   Brain. 2019 Jul 13. pii: 5532100. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
6. WENTLING M, Lopez-Gomez C, Park HJ, Amatruda M, et al
   A metabolic perspective on CSF-mediated neurodegeneration in multiple sclerosis.
   Brain. 2019 Jul 15. pii: 5531715. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   

   
   Diabet Med

7. HAUFFE F, Schaefer-Graf UM, Fauzan R, Schohe AL, et al
   Higher rates of large-for-gestational-age newborns mediated by excess maternal weight gain in pregnancies with Type 1 diabetes and use of continuous subcutaneous insulin infusion vs multiple dose insulin injection.
   Diabet Med. 2019;36:158-166.
   PubMed     Text format     Abstract available
   
   
8. SAMII L, Kallas-Koeman M, Donovan LE, Lodha A, et al
   The association between vascular complications during pregnancy in women with Type 1 diabetes and congenital malformations.
   Diabet Med. 2018 Nov 30. doi: 10.1111/dme.13872.
   PubMed     Text format     Abstract available
   
   
9. ALVARO-AFONSO FJ, Lazaro-Martinez JL, Garcia-Morales E, Garcia-Alvarez Y, et al
   Cortical disruption is the most reliable and accurate plain radiographic sign in the diagnosis of diabetic foot osteomyelitis.
   Diabet Med. 2018 Sep 23. doi: 10.1111/dme.13824.
   PubMed     Text format     Abstract available
   
   

   
   Diabetes

10. KALLIONPAA H, Somani J, Tuomela S, Ullah U, et al
    Early Detection of Peripheral Blood Cell Signature in Children Developing Beta-Cell Autoimmunity at a Young Age.
    Diabetes. 2019 Jul 16. pii: db19-0287. doi: 10.2337/db19-0287.
    PubMed     Text format     Abstract available
    
    

    
    J Autoimmun

11. PACHECO Y, Acosta-Ampudia Y, Monsalve DM, Chang C, et al
    Bystander activation and autoimmunity.
    J Autoimmun. 2019 Jul 17:102301. doi: 10.1016/j.jaut.2019.
    PubMed     Text format     Abstract available
    
    
12. MEIER HCS, Parks CG, Liu HB, Sandler DP, et al
    Cellular aging over 13 years associated with incident antinuclear antibody positivity in the Baltimore Longitudinal Study of Aging.
    J Autoimmun. 2019 Jul 11. pii: S0896-8411(19)30210.
    PubMed     Text format     Abstract available
    
    
13. SHIN JI, Lee KH, Joo YH, Lee JM, et al
    Inflammasomes and autoimmune and rheumatic diseases: A comprehensive review.
    J Autoimmun. 2019 Jul 17:102299. doi: 10.1016/j.jaut.2019.
    PubMed     Text format     Abstract available
    
    

    
    J Immunol

14. AKIYAMA C, Tsumiyama K, Uchimura C, Honda E, et al
    Conditional Upregulation of IFN-alpha Alone Is Sufficient to Induce Systemic Lupus Erythematosus.
    J Immunol. 2019 Jul 19. pii: jimmunol.1801617. doi: 10.4049/jimmunol.1801617.
    PubMed     Text format     Abstract available
    
    

    
    J Neurol

15. MO XB, Lei SF, Qian QY, Guo YF, et al
    Integrative analysis revealed potential causal genetic and epigenetic factors for multiple sclerosis.
    J Neurol. 2019 Jul 18. pii: 10.1007/s00415-019-09476.
    PubMed     Text format     Abstract available
    
    
16. MICHAEL G, Christian E, Fritz L, Jorg K, et al
    Switching from natalizumab to fingolimod treatment in multiple sclerosis: real life data from the Austrian MS Treatment Registry.
    J Neurol. 2019 Jul 16. pii: 10.1007/s00415-019-09464.
    PubMed     Text format     Abstract available
    
    
17. RAIMO S, Trojano L, Gaita M, Spitaleri D, et al
    High openness and high extroversion are linked with better time-based prospective memory in multiple sclerosis.
    J Neurol. 2019 Jul 16. pii: 10.1007/s00415-019-09460.
    PubMed     Text format     Abstract available
    
    

    
    J Rheumatol

18. BREKKE LK, Fevang BS, Diamantopoulos AP, Assmus J, et al
    Risk of cancer in 767 patients with giant cell arteritis in western Norway: a retrospective cohort with matched controls.
    J Rheumatol. 2019 Jul 15. pii: jrheum.190147. doi: 10.3899/jrheum.190147.
    PubMed     Text format     Abstract available
    
    

    
    Lancet Neurol

19. PLOUGHMAN M
    Restoring function in progressive multiple sclerosis.
    Lancet Neurol. 2019;18:711-712.
    PubMed     Text format    
    
    
20. FREEMAN J, Hendrie W, Jarrett L, Hawton A, et al
    Assessment of a home-based standing frame programme in people with progressive multiple sclerosis (SUMS): a pragmatic, multi-centre, randomised, controlled trial and cost-effectiveness analysis.
    Lancet Neurol. 2019;18:736-747.
    PubMed     Text format     Abstract available
    
    

    
    Mult Scler

21. HACOHEN Y, Brownlee W, Mankad K, Chong WK', et al
    Improved performance of the 2017 McDonald criteria for diagnosis of multiple sclerosis in children in a real-life cohort.
    Mult Scler. 2019 Jul 18:1352458519863781. doi: 10.1177/1352458519863781.
    PubMed     Text format     Abstract available
    
    
22. CAMARA-LEMARROY CR, Silva C, Greenfield J, Liu WQ, et al
    Biomarkers of intestinal barrier function in multiple sclerosis are associated with disease activity.
    Mult Scler. 2019 Jul 18:1352458519863133. doi: 10.1177/1352458519863133.
    PubMed     Text format     Abstract available
    
    

    
    N Engl J Med

23. CHEN Z, Wang X, Ye S
    Tofacitinib in Amyopathic Dermatomyositis-Associated Interstitial Lung Disease.
    N Engl J Med. 2019;381:291-293.
    PubMed     Text format    
    
    

    
    Neurology

24. TITULAER MJ, Irani SR, Lassmann H
    PDE10A antibodies in autoimmune encephalitis: A possible marker of cancer immunotherapy?
    Neurology. 2019 Jul 17. pii: WNL.0000000000007965.
    PubMed     Text format    
    
    
25. ZEKERIDOU A, Kryzer T, Guo Y, Hassan A, et al
    Phosphodiesterase 10A IgG: A novel biomarker of paraneoplastic neurologic autoimmunity.
    Neurology. 2019 Jul 17. pii: WNL.0000000000007971.
    PubMed     Text format     Abstract available
    
    

    
    Thyroid

26. AZIZI F, Amouzegar A, Tohidi M, Hedayati M, et al
    Increased remission rates after long-term methimazole therapy in patients with Graves' disease: Results of a randomized clinical trial.
    Thyroid. 2019 Jul 16. doi: 10.1089/thy.2019.0180.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: